NCT03962998 - Oral Administration of MB-102 Versus Dual Sugar Testing for Gut Permeability | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 27, 2019

Primary Completion Date

October 5, 2021

Study Completion Date

October 5, 2021

Conditions

Crohn Disease

Interventions

DRUG

Lactulose/Rhamnose solution

Lactulose/Rhamnose solution administered orally followed by measurement of excreted lactulose and rhamnose in urine

DRUG

MB-102

MB-102 solution administered orally followed by measurement of excreted MB-102 in urine

Trial Locations (1)

Washington University in St. Louis, St Louis